Methods for non-invasive assessment of copy number alterations

    公开(公告)号:US11929143B2

    公开(公告)日:2024-03-12

    申请号:US16477923

    申请日:2018-01-22

    Applicant: Sequenom, Inc.

    CPC classification number: G16B20/10 C12Q1/68 G16B20/20 G16B30/10 G16B40/00

    Abstract: Technology provided herein relates in part to methods, processes, machines and apparatuses for non-invasive assessment of copy number alterations. In particular, a method is provided for determining presence or absence of a copy number alteration for a test subject. The method includes providing a set of sequence reads. The sequence reads may be obtained from circulating cell free sample nucleic acid from a test sample obtained from the test subject, and the circulating cell free sample nucleic acid may be captured by probe oligonucleotides under hybridization conditions. The method further includes determining a probe coverage quantification of the sequence reads for the probe oligonucleotides and determining the presence or absence of a copy number alteration in the circulating cell free sample nucleic acid based on the probe coverage quantification of the sequence reads for the probe oligonucleotides for the test sample.

    Genetic Copy Number Alteration Classifications

    公开(公告)号:US20180032671A1

    公开(公告)日:2018-02-01

    申请号:US15661804

    申请日:2017-07-27

    Applicant: Sequenom, Inc.

    CPC classification number: G16B40/00 G06N7/005 G16B20/00

    Abstract: Technology provided herein relates in part to non-invasive classification of one or more genetic copy number alterations (CNAs) for a test sample. Certain methods include sampling a quantification of sequence reads from parts of a genome, generating a confidence determination, and using the confidence determination to enhance classification. Technology provided herein is useful for classifying a genetic CNA for a sample as part of non-invasive pre-natal (NIPT) testing and oncology testing, for example.

Patent Agency Ranking